Your browser doesn't support javascript.
loading
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study).
Hwang, Kihwan; Kim, Tae Min; Park, Chul-Kee; Chang, Jong Hee; Jung, Tae-Young; Kim, Jin Hee; Nam, Do-Hyun; Kim, Se-Hyuk; Yoo, Heon; Hong, Yong-Kil; Kim, Eun-Young; Lee, Dong-Eun; Joo, Jungnam; Kim, Yu Jung; Choe, Gheeyoung; Choi, Byung Se; Kang, Seok-Gu; Kim, Jeong Hoon; Kim, Chae-Yong.
Afiliación
  • Hwang K; Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Park CK; Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Chang JH; Department of Neurosurgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Jung TY; Department of Neurosurgery, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Kim JH; Department of Radiation Oncology, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
  • Nam DH; Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim SH; Department of Neurosurgery, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea.
  • Yoo H; Department of Neuro-Oncology Clinic, Center for Specific Organs Cancer, National Cancer Center Hospital, National Cancer Center, Goyang, Korea.
  • Hong YK; Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kim EY; Department of Neurosurgery, Inha University Hospital, Inha University School of Medicine, Incheon, Korea.
  • Lee DE; Division of Cancer Epidemiology and Management, Research Institute, National Cancer Center, Goyang, Korea.
  • Joo J; Division of Cancer Epidemiology and Management, Research Institute, National Cancer Center, Goyang, Korea.
  • Kim YJ; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Choe G; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Choi BS; Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Kang SG; Department of Neurosurgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Kim JH; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim CY; Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Cancer Res Treat ; 52(2): 505-515, 2020 Apr.
Article en En | MEDLINE | ID: mdl-31671938
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Alquilantes / Temozolomida / Glioma Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Cancer Res Treat Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Alquilantes / Temozolomida / Glioma Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Cancer Res Treat Año: 2020 Tipo del documento: Article